Trademark owner · USPTO register · rebuilt nightly

Novartis Pharma AG

51 live US trademarks, filing since 2003. 35 new applications filed this year.

Live marks
51
registered + pending
Registered
30
on the Principal Register
Pending
21
6 open to opposition
Filed in 2026
35
by filing date
Classes used
7
of 45 Nice classes
First filing
2003
23 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 37 of 51 live marks are in Class 5. Medical & beauty services (Class 44) is next with 10.
Filing faster than usual: 35 applications so far in 2026 against a yearly average of 0.7.
Entering Class 9 (electronics & software) and Class 35 (advertising & business): first filings this year in a class with no earlier Novartis Pharma AG marks.
6 marks are open to opposition now; the windows close between Nov 12 and Nov 12.
Filing activityapplications per year, by filing date
0 37 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 37 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Novartis Pharma AG filed most recently.

MarkClassFiledBasisStatusSerial
GOODBRIDGE 35, 42, 44 Jun 19, 2026 — pending 99894846
ARCOMES 35, 42, 44 Jun 19, 2026 — pending 99894850
MOVIVDYS 5 Jun 3, 2026 — published · closes Dec 3 79457863
JETFIRSO 5 May 26, 2026 in use published · closes Nov 26 79457856
BETFIRZIO 5 May 26, 2026 — pending 79458521
BRETFIRSO 5 May 26, 2026 — pending 79458524
ANTHOS 42, 44 May 22, 2026 — pending 99840373
ETFIRSO 5 May 22, 2026 — published · closes Dec 3 79458519
MYZIZUN 5 May 12, 2026 — published · closes Nov 12 79454228
AGLYNFI 5 May 12, 2026 — published · closes Nov 12 79454229
Open to opposition now30-day windows from publication
MYZIZUN · Cl. 5 · published Oct 13
closes Nov 12
AGLYNFI · Cl. 5 · published Oct 13
closes Nov 12
LEONIJU · Cl. 5 · published Oct 13
closes Nov 12
ALWIVKU · Cl. 5 · published Oct 13
closes Nov 12
APKAYER · Cl. 5 · published Oct 13
closes Nov 12
FIPQLYE · Cl. 5 · published Oct 13
closes Nov 12

Anyone who believes they would be harmed by registration can oppose during this window.

Recently registeredlast 12 months
DELVIBZY · Cl. 5 · Reg. 8,508,298
Oct 20, 2026
DUXIVRY · Cl. 5 · Reg. 8,508,304
Oct 20, 2026
TEYMUVA · Cl. 5 · Reg. 8,508,308
Oct 20, 2026
DYSVARNA · Cl. 5 · Reg. 8,508,305
Oct 20, 2026
DUXEMLY · Cl. 5 · Reg. 8,508,306
Oct 20, 2026
DEMKINZY · Cl. 5 · Reg. 8,508,307
Oct 20, 2026
MYOKENTA · Cl. 5 · Reg. 8,508,309
Oct 20, 2026
GARDMYOS · Cl. 5 · Reg. 8,508,310
Oct 20, 2026

Registration starts the maintenance clock: a Section 8 declaration is due between years 5 and 6.

Other large filers in Class 5Full ranking →
Common questions

About Novartis Pharma AG trademarks.

How many trademarks does Novartis Pharma AG have?

51 live US trademarks as of October 23, 2026: 30 registered and 21 pending applications. 35 were filed in 2026 so far.

What does Novartis Pharma AG sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 37 live marks). Also medical & beauty services (Class 44) and science & technology (saas) (Class 42).

Who owns the TYKERB trademark?

TYKERB is owned by Novartis Pharma AG. It was registered on October 19, 2004 (Reg. No. 2895608) and is live. The same owner holds 50 other live US marks.

When did Novartis Pharma AG first file a trademark?

Its oldest live US filing dates from 2003: TYKERB, filed August 5, 2003.

Know the morning after Novartis Pharma AG files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.